Strengthening the R&D Structure Through the Establishment of D-LAB
First written in FY2020-Q1. 4 of 5 entries say "Advanced", first in FY2020. Latest entry: FY2024.
The whole theme swung hardest in 2025: 1 of 6 companies on the "Worse" side.
2 other companies' latest entry also says "Advanced".
- FY2024AdvancedAnnual report
「The Group's R&D expenses for the year amounted to ¥78.6 billion, including ¥13.5 billion in R&D expenses related to basic research not attributable to any segment.」
R&D expenses including D-LAB and basic research increased from ¥70.8 billion in the previous fiscal year to ¥78.6 billion, while the relevant component also increased from ¥10.3 billion to ¥13.5 billion. - FY2022AdvancedAnnual report
「The Group's R&D expenses for the year amounted to ¥70.8 billion. The research objectives and R&D expenses of each segment are as follows. The R&D expenses described above include expenses incurred by D-LAB, an organisation established within our corporate division for research and development purposes, and ¥10.3 billion in R&D expenses related to basic research not attributable to any segment.」
R&D expenses including D-LAB and basic research amounted to ¥70.8 billion for the year, with the relevant component disclosed as ¥10.3 billion. - FY2021AdvancedAnnual report
「The Group's R&D expenses for the year amounted to ¥65 billion. The research objectives and R&D expenses of each segment are as follows. The R&D expenses described above include expenses incurred by D-LAB, an organisation established within our corporate division for research and development purposes, and ¥7.3 billion in R&D expenses related to basic research not attributable to any segment.」
R&D expenses including D-LAB amounted to ¥65 billion for the year, and D-LAB and basic research expenses were disclosed as ¥7.3 billion. - FY2020AdvancedAnnual report
「In January 2020, we established D-LAB as an organisation within our corporate division for research and development purposes. The R&D expenses described above include expenses incurred by this organisation and ¥6.5 billion in R&D expenses related to basic research not attributable to any segment.」
Basic research and other expenses, including D-LAB's R&D expenses, amounted to ¥6.5 billion, and the breakdown of annual R&D expenses of ¥60.8 billion was disclosed. - FY2020-Q1First statedAnnual report
「In January 2020, we established D-LAB as an organisation within our corporate division for research and development purposes, and from the first quarter of the current consolidated cumulative period, expenses incurred by this organisation have been included in R&D expenses.」
In January 2020, D-LAB was established within the corporate division for research and development purposes, and its expenses were included in R&D expenses from the first quarter.